source
- Revolution Medicines' Daraxonrasib Doubles Survival in Pancreatic Cancer Trial, Study ShowsResults from a late-stage trial of the experimental pill daraxonrasib were presented at the American Society of Clinical Oncology meeting. The data showed that patients receiving the drug lived alm…
- Revolution Medicines' pancreatic cancer trial shows striking positive resultsAt the American Society of Clinical Oncology meeting, Revolution Medicines presented data from its pivotal pancreatic cancer trial that impressed many observers. Oncologist Brian Wolpin described…